Artificial intelligence is reshaping biotech, but separating promise from proof has never been more important.

Join us for a candid, peer-level conversation that brings together biotech leaders to examine how AI is applied across the drug discovery and development lifecycle. The focus is practical and grounded: how AI is improving productivity, reducing time and cost, increasing the probability of success, and ultimately accelerating the delivery of medicines to patients. Designed as a trusted forum for healthcare leaders, this session cuts through the hype to explore where AI is delivering measurable value today and where organizations continue to face real challenges. Through executive-level insights and concrete examples, the discussion will examine how leading companies are deploying AI across the discovery, preclinical, and clinical phases, and the strategic decisions required to scale AI responsibly and effectively.

YPOers are encouraged to submit questions in advance to help shape the live discussion and ensure they are relevant to member priorities.

Key takeaways:
1. Lessons from the Front Lines: Success factors, challenges, and insights from biotech leaders.
2. Value Creation Clarity: Where AI is reducing timelines, lowering costs, and improving decision-making.
3. Real-World Applications: How AI is used today across discovery, preclinical, and clinical development.
4. Leadership Frameworks: Actionable questions to assess AI’s potential within your organization or investment portfolio.

Witness where AI is moving the needle in biotech. Register now.